{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:51:42Z","timestamp":1787849502332,"version":"build-2784847793"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NCH high school summer scientist's internship program"},{"name":"NIH","award":["AR049722"],"award-info":[{"award-number":["AR049722"]}]},{"name":"Technology Transfer"},{"DOI":"10.13039\/100007520","name":"Nationwide Children's Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.nbd.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,8]],"date-time":"2013-09-08T04:46:32Z","timestamp":1378615592000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease"],"prefix":"10.1016","volume":"62","author":[{"given":"Marybeth","family":"Camboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiou-Miin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hae","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Kaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.09.001_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.42.1.115","article-title":"Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study","volume":"42","author":"Bachman","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.09.001_bb0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1073\/pnas.0436286100","article-title":"Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology","volume":"100","author":"Bard","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.09.001_bb0015","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide oligomer \u2014 a homogenous and stable neuropathological protein in Alzheimer's disease","volume":"95","author":"Barghorn","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2013.09.001_bb0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.09.001_bb0030","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1523\/JNEUROSCI.22-24-10539.2002","article-title":"Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation","volume":"22","author":"Buttini","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0025","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1523\/JNEUROSCI.1697-05.2005","article-title":"Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease","volume":"25","author":"Buttini","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-2094-3-11","article-title":"Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice","volume":"3","author":"Carty","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2013.09.001_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.it.2009.05.002","article-title":"Vaccination in the elderly: an immunological perspective","volume":"30","author":"Chen","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/187152710791012080","article-title":"Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention","volume":"9","author":"Cribbs","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2013.09.001_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2013.09.001_bb0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1471-4159.2011.07458.x","article-title":"\u2018Clinical trials in Alzheimer's disease\u2019: immunotherapy approaches","volume":"120","author":"Delrieu","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2013.09.001_bb0065","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.09.001_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0075","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.vaccine.2005.11.039","article-title":"Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch","volume":"24","author":"Ghochikyan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.nbd.2013.09.001_bb0080","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.09.001_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.nbd.2013.09.001_bb0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.09.001_bb0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.immuni.2006.06.003","article-title":"Why aging T cells fail: implications for vaccination","volume":"24","author":"Haynes","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.nbd.2013.09.001_bb0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","volume":"38","author":"Hock","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.09.001_bb0105","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0002-9440(10)64639-1","article-title":"Antibody-mediated resolution of light chain-associated amyloid deposits","volume":"157","author":"Hrncic","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","article-title":"AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss","volume":"52","author":"Hsieh","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.09.001_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: a comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.nbd.2013.09.001_bb0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0960-8966(03)00040-3","article-title":"Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice","volume":"13","author":"Jayasinha","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2013.09.001_bb0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0969-9961(03)00105-0","article-title":"Identification of peptides that specifically bind Abeta1\u201340 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display","volume":"14","author":"Kang","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.09.001_bb0135","doi-asserted-by":"crossref","first-page":"C1309","DOI":"10.1152\/ajpcell.00353.2002","article-title":"A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis","volume":"284","author":"Kelly","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0140","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1523\/JNEUROSCI.21-04-01327.2001","article-title":"Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo","volume":"21","author":"Kim","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5414\/NPP26043","article-title":"A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases","volume":"26","author":"Lace","year":"2007","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.490390404","article-title":"Beta\/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells","volume":"39","author":"Lambert","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2013.09.001_bb0150","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1\u201342 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.09.001_bb0160","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1212\/WNL.0b013e3181e03844","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"74","author":"Laskowitz","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.09.001_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0079-6123(09)17506-4","article-title":"Developing novel immunogens for a safe and effective Alzheimer's disease vaccine","volume":"175","author":"Lemere","year":"2009","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2013.09.001_bb0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","article-title":"Can Alzheimer disease be prevented by amyloid-beta immunotherapy?","volume":"6","author":"Lemere","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0175","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2013.09.001_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI25410","article-title":"Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model","volume":"116","author":"Levites","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2013.09.001_bb0185","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1523\/JNEUROSCI.2795-06.2006","article-title":"Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice","volume":"26","author":"Levites","year":"2006","journal-title":"J. Neurosci. Official J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0190","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/978-3-7091-0932-8_25","article-title":"Synaptic dysfunction in Alzheimer's disease","volume":"970","author":"Marcello","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0195","first-page":"235","article-title":"Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease","volume":"138","author":"Masliah","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI200318104","article-title":"Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease","volume":"112","author":"Monsonego","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2013.09.001_bb0205","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1074\/jbc.R800030200","article-title":"Relevance of transgenic mouse models to human Alzheimer disease","volume":"284","author":"Morrissette","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2013.09.001_bb0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0215","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","article-title":"Abeta species removal after abeta42 immunization","volume":"65","author":"Nicoll","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0220","doi-asserted-by":"crossref","first-page":"13049","DOI":"10.1021\/bi701255m","article-title":"Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope","volume":"46","author":"O'Nuallain","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2013.09.001_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.09.001_bb0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","article-title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","volume":"69","author":"Ostrowitzki","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0045-6039(84)90038-1","article-title":"Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation","volume":"14","author":"Pahlman","year":"1984","journal-title":"Cell Differ."},{"key":"10.1016\/j.nbd.2013.09.001_bb0240","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/imt.11.170","article-title":"Immunotherapy for Alzheimer's disease: from anti-beta-amyloid to tau-based immunization strategies","volume":"4","author":"Panza","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.nbd.2013.09.001_bb0245","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.200425848","article-title":"Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching","volume":"35","author":"Park","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0250","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/j.1742-4658.2010.07719.x","article-title":"Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins","volume":"277","author":"Pham","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2013.09.001_bb0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000113700","article-title":"Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis","volume":"5","author":"Pride","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.nbd.2013.09.001_bb0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-2011-101809","article-title":"Neuropathology and amyloid-beta spectrum in a bapineuzumab immunotherapy recipient","volume":"24","author":"Roher","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2013.09.001_bb0265","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","article-title":"Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities","volume":"18","author":"Savonenko","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.09.001_bb0270","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2003.08.002","article-title":"Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies","volume":"24","author":"Scheff","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2013.09.001_bb0275","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.jalz.2007.11.009","article-title":"Current challenges for the successful treatment and prevention of Alzheimer's disease: treating the pathologies of the disease to change its clinical course","volume":"4","author":"Schenk","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2013.09.001_bb0280","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2013.09.001_bb0285","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/erv.11.21","article-title":"Trends in vaccine adjuvants","volume":"10","author":"Schijns","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.nbd.2013.09.001_bb0290","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12603-009-0070-5","article-title":"Development of AFFITOPE vaccines for Alzheimer's disease (AD)\u2014from concept to clinical testing","volume":"13","author":"Schneeberger","year":"2009","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.nbd.2013.09.001_bb0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2013.09.001_bb0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2013.09.001_bb0305","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2013.09.001_bb0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2009.07.021","article-title":"Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life","volume":"36","author":"Shankar","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.09.001_bb0320","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","article-title":"Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease","volume":"56","author":"Sze","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1620\/tjem.220.95","article-title":"Immunization therapy for Alzheimer disease: a comprehensive review of active immunization strategies","volume":"220","author":"Tabira","year":"2010","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.nbd.2013.09.001_bb0330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2011.04.010","article-title":"A mimotope peptide of Abeta42 fibril-specific antibodies with Abeta42 fibrillation inhibitory activity induces anti-Abeta42 conformer antibody response by a displayed form on an M13 phage in mice","volume":"236","author":"Tanaka","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0335","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00005072-199655100-00001","article-title":"The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis","volume":"55","author":"Terry","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0340","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jmcb\/mjr033","article-title":"TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells","volume":"4","author":"Tran","year":"2012","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2013.09.001_bb0350","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/jnr.21670","article-title":"Amyloid beta peptide toxicity in differentiated PC12 cells: calpain\u2013calpastatin, caspase, and membrane damage","volume":"86","author":"Vaisid","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2013.09.001_bb0355","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2013.09.001_bb0360","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2010.05.013","article-title":"Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease","volume":"39","author":"Wang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.09.001_bb0365","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nn.2476","article-title":"Amyloid beta from axons and dendrites reduces local spine number and plasticity","volume":"13","author":"Wei","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0370","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","article-title":"Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation","volume":"23","author":"Wilcock","year":"2003","journal-title":"J. Neurosci. Official J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0375","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1523\/JNEUROSCI.2021-09.2009","article-title":"Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta","volume":"29","author":"Yamada","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.09.001_bb0380","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.mcn.2009.04.013","article-title":"The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: partial dependence on utrophin","volume":"41","author":"Yoon","year":"2009","journal-title":"Mol. Cell. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T12:29:24Z","timestamp":1563884964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":76,"alternative-id":["S0969996113002374"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.09.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}